Global Biologics Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
LPI (LP Information)' newest research report, the “Biologics Industry Forecast” looks at past sales and reviews total world Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologics sales for 2023 through 2029. With Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics industry.
This Insight Report provides a comprehensive analysis of the global Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics.
The global Biologics market size is projected to grow from US$ 101890 million in 2022 to US$ 147350 million in 2029; it is expected to grow at a CAGR of 147350 from 2023 to 2029.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Biologics market?
What factors are driving Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biologics market opportunities vary by end market size?
How does Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
LPI (LP Information)' newest research report, the “Biologics Industry Forecast” looks at past sales and reviews total world Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologics sales for 2023 through 2029. With Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics industry.
This Insight Report provides a comprehensive analysis of the global Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics.
The global Biologics market size is projected to grow from US$ 101890 million in 2022 to US$ 147350 million in 2029; it is expected to grow at a CAGR of 147350 from 2023 to 2029.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Antisense
- RNAi
- Infectious Diseases
- Oncology
- Immunology
- Autoimmune Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly & Company
- Samsung Biologics
- F Hoffman La Roche
- Celltrion
- Addgene
- Amgen
- Abbvie Inc.
- Sanofi
- Pfizer Inc.
- Merck & Co. Inc.
- Novo Nordisk A/S
- Johnson & Johnson Services Inc.
What is the 10-year outlook for the global Biologics market?
What factors are driving Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biologics market opportunities vary by end market size?
How does Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biologics by Country/Region, 2018, 2022 & 2029
2.2 Biologics Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Vaccines
2.2.3 Recombinant Proteins
2.2.4 Antisense
2.2.5 RNAi
2.3 Biologics Sales by Type
2.3.1 Global Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biologics Sale Price by Type (2018-2023)
2.4 Biologics Segment by Application
2.4.1 Infectious Diseases
2.4.2 Oncology
2.4.3 Immunology
2.4.4 Autoimmune Diseases
2.5 Biologics Sales by Application
2.5.1 Global Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biologics Sale Price by Application (2018-2023)
3 GLOBAL BIOLOGICS BY COMPANY
3.1 Global Biologics Breakdown Data by Company
3.1.1 Global Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Biologics Sales Market Share by Company (2018-2023)
3.2 Global Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Biologics Revenue by Company (2018-2023)
3.2.2 Global Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Biologics Sale Price by Company
3.4 Key Manufacturers Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologics Product Location Distribution
3.4.2 Players Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biologics Sales Growth
4.4 APAC Biologics Sales Growth
4.5 Europe Biologics Sales Growth
4.6 Middle East & Africa Biologics Sales Growth
5 AMERICAS
5.1 Americas Biologics Sales by Country
5.1.1 Americas Biologics Sales by Country (2018-2023)
5.1.2 Americas Biologics Revenue by Country (2018-2023)
5.2 Americas Biologics Sales by Type
5.3 Americas Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Sales by Region
6.1.1 APAC Biologics Sales by Region (2018-2023)
6.1.2 APAC Biologics Revenue by Region (2018-2023)
6.2 APAC Biologics Sales by Type
6.3 APAC Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologics by Country
7.1.1 Europe Biologics Sales by Country (2018-2023)
7.1.2 Europe Biologics Revenue by Country (2018-2023)
7.2 Europe Biologics Sales by Type
7.3 Europe Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics by Country
8.1.1 Middle East & Africa Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Biologics Sales by Type
8.3 Middle East & Africa Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologics
10.3 Manufacturing Process Analysis of Biologics
10.4 Industry Chain Structure of Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologics Distributors
11.3 Biologics Customer
12 WORLD FORECAST REVIEW FOR BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Biologics Market Size Forecast by Region
12.1.1 Global Biologics Forecast by Region (2024-2029)
12.1.2 Global Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biologics Forecast by Type
12.7 Global Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly & Company
13.1.1 Eli Lilly & Company Company Information
13.1.2 Eli Lilly & Company Biologics Product Portfolios and Specifications
13.1.3 Eli Lilly & Company Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly & Company Main Business Overview
13.1.5 Eli Lilly & Company Latest Developments
13.2 Samsung Biologics
13.2.1 Samsung Biologics Company Information
13.2.2 Samsung Biologics Biologics Product Portfolios and Specifications
13.2.3 Samsung Biologics Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Samsung Biologics Main Business Overview
13.2.5 Samsung Biologics Latest Developments
13.3 F Hoffman La Roche
13.3.1 F Hoffman La Roche Company Information
13.3.2 F Hoffman La Roche Biologics Product Portfolios and Specifications
13.3.3 F Hoffman La Roche Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 F Hoffman La Roche Main Business Overview
13.3.5 F Hoffman La Roche Latest Developments
13.4 Celltrion
13.4.1 Celltrion Company Information
13.4.2 Celltrion Biologics Product Portfolios and Specifications
13.4.3 Celltrion Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Celltrion Main Business Overview
13.4.5 Celltrion Latest Developments
13.5 Addgene
13.5.1 Addgene Company Information
13.5.2 Addgene Biologics Product Portfolios and Specifications
13.5.3 Addgene Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Addgene Main Business Overview
13.5.5 Addgene Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Biologics Product Portfolios and Specifications
13.6.3 Amgen Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Abbvie Inc.
13.7.1 Abbvie Inc. Company Information
13.7.2 Abbvie Inc. Biologics Product Portfolios and Specifications
13.7.3 Abbvie Inc. Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbvie Inc. Main Business Overview
13.7.5 Abbvie Inc. Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Biologics Product Portfolios and Specifications
13.8.3 Sanofi Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Company Information
13.9.2 Pfizer Inc. Biologics Product Portfolios and Specifications
13.9.3 Pfizer Inc. Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Pfizer Inc. Main Business Overview
13.9.5 Pfizer Inc. Latest Developments
13.10 Merck & Co. Inc.
13.10.1 Merck & Co. Inc. Company Information
13.10.2 Merck & Co. Inc. Biologics Product Portfolios and Specifications
13.10.3 Merck & Co. Inc. Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merck & Co. Inc. Main Business Overview
13.10.5 Merck & Co. Inc. Latest Developments
13.11 Novo Nordisk A/S
13.11.1 Novo Nordisk A/S Company Information
13.11.2 Novo Nordisk A/S Biologics Product Portfolios and Specifications
13.11.3 Novo Nordisk A/S Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novo Nordisk A/S Main Business Overview
13.11.5 Novo Nordisk A/S Latest Developments
13.12 Johnson & Johnson Services Inc.
13.12.1 Johnson & Johnson Services Inc. Company Information
13.12.2 Johnson & Johnson Services Inc. Biologics Product Portfolios and Specifications
13.12.3 Johnson & Johnson Services Inc. Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Johnson & Johnson Services Inc. Main Business Overview
13.12.5 Johnson & Johnson Services Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biologics by Country/Region, 2018, 2022 & 2029
2.2 Biologics Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Vaccines
2.2.3 Recombinant Proteins
2.2.4 Antisense
2.2.5 RNAi
2.3 Biologics Sales by Type
2.3.1 Global Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biologics Sale Price by Type (2018-2023)
2.4 Biologics Segment by Application
2.4.1 Infectious Diseases
2.4.2 Oncology
2.4.3 Immunology
2.4.4 Autoimmune Diseases
2.5 Biologics Sales by Application
2.5.1 Global Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biologics Sale Price by Application (2018-2023)
3 GLOBAL BIOLOGICS BY COMPANY
3.1 Global Biologics Breakdown Data by Company
3.1.1 Global Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Biologics Sales Market Share by Company (2018-2023)
3.2 Global Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Biologics Revenue by Company (2018-2023)
3.2.2 Global Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Biologics Sale Price by Company
3.4 Key Manufacturers Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologics Product Location Distribution
3.4.2 Players Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biologics Sales Growth
4.4 APAC Biologics Sales Growth
4.5 Europe Biologics Sales Growth
4.6 Middle East & Africa Biologics Sales Growth
5 AMERICAS
5.1 Americas Biologics Sales by Country
5.1.1 Americas Biologics Sales by Country (2018-2023)
5.1.2 Americas Biologics Revenue by Country (2018-2023)
5.2 Americas Biologics Sales by Type
5.3 Americas Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics Sales by Region
6.1.1 APAC Biologics Sales by Region (2018-2023)
6.1.2 APAC Biologics Revenue by Region (2018-2023)
6.2 APAC Biologics Sales by Type
6.3 APAC Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologics by Country
7.1.1 Europe Biologics Sales by Country (2018-2023)
7.1.2 Europe Biologics Revenue by Country (2018-2023)
7.2 Europe Biologics Sales by Type
7.3 Europe Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologics by Country
8.1.1 Middle East & Africa Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Biologics Sales by Type
8.3 Middle East & Africa Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologics
10.3 Manufacturing Process Analysis of Biologics
10.4 Industry Chain Structure of Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologics Distributors
11.3 Biologics Customer
12 WORLD FORECAST REVIEW FOR BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Biologics Market Size Forecast by Region
12.1.1 Global Biologics Forecast by Region (2024-2029)
12.1.2 Global Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biologics Forecast by Type
12.7 Global Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly & Company
13.1.1 Eli Lilly & Company Company Information
13.1.2 Eli Lilly & Company Biologics Product Portfolios and Specifications
13.1.3 Eli Lilly & Company Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eli Lilly & Company Main Business Overview
13.1.5 Eli Lilly & Company Latest Developments
13.2 Samsung Biologics
13.2.1 Samsung Biologics Company Information
13.2.2 Samsung Biologics Biologics Product Portfolios and Specifications
13.2.3 Samsung Biologics Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Samsung Biologics Main Business Overview
13.2.5 Samsung Biologics Latest Developments
13.3 F Hoffman La Roche
13.3.1 F Hoffman La Roche Company Information
13.3.2 F Hoffman La Roche Biologics Product Portfolios and Specifications
13.3.3 F Hoffman La Roche Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 F Hoffman La Roche Main Business Overview
13.3.5 F Hoffman La Roche Latest Developments
13.4 Celltrion
13.4.1 Celltrion Company Information
13.4.2 Celltrion Biologics Product Portfolios and Specifications
13.4.3 Celltrion Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Celltrion Main Business Overview
13.4.5 Celltrion Latest Developments
13.5 Addgene
13.5.1 Addgene Company Information
13.5.2 Addgene Biologics Product Portfolios and Specifications
13.5.3 Addgene Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Addgene Main Business Overview
13.5.5 Addgene Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Biologics Product Portfolios and Specifications
13.6.3 Amgen Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Abbvie Inc.
13.7.1 Abbvie Inc. Company Information
13.7.2 Abbvie Inc. Biologics Product Portfolios and Specifications
13.7.3 Abbvie Inc. Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbvie Inc. Main Business Overview
13.7.5 Abbvie Inc. Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Biologics Product Portfolios and Specifications
13.8.3 Sanofi Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Company Information
13.9.2 Pfizer Inc. Biologics Product Portfolios and Specifications
13.9.3 Pfizer Inc. Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Pfizer Inc. Main Business Overview
13.9.5 Pfizer Inc. Latest Developments
13.10 Merck & Co. Inc.
13.10.1 Merck & Co. Inc. Company Information
13.10.2 Merck & Co. Inc. Biologics Product Portfolios and Specifications
13.10.3 Merck & Co. Inc. Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merck & Co. Inc. Main Business Overview
13.10.5 Merck & Co. Inc. Latest Developments
13.11 Novo Nordisk A/S
13.11.1 Novo Nordisk A/S Company Information
13.11.2 Novo Nordisk A/S Biologics Product Portfolios and Specifications
13.11.3 Novo Nordisk A/S Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novo Nordisk A/S Main Business Overview
13.11.5 Novo Nordisk A/S Latest Developments
13.12 Johnson & Johnson Services Inc.
13.12.1 Johnson & Johnson Services Inc. Company Information
13.12.2 Johnson & Johnson Services Inc. Biologics Product Portfolios and Specifications
13.12.3 Johnson & Johnson Services Inc. Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Johnson & Johnson Services Inc. Main Business Overview
13.12.5 Johnson & Johnson Services Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Vaccines
Table 5. Major Players of Recombinant Proteins
Table 6. Major Players of Antisense
Table 7. Major Players of RNAi
Table 8. Global Biologics Sales by Type (2018-2023) & (K MT)
Table 9. Global Biologics Sales Market Share by Type (2018-2023)
Table 10. Global Biologics Revenue by Type (2018-2023) & ($ million)
Table 11. Global Biologics Revenue Market Share by Type (2018-2023)
Table 12. Global Biologics Sale Price by Type (2018-2023) & (USD/MT)
Table 13. Global Biologics Sales by Application (2018-2023) & (K MT)
Table 14. Global Biologics Sales Market Share by Application (2018-2023)
Table 15. Global Biologics Revenue by Application (2018-2023)
Table 16. Global Biologics Revenue Market Share by Application (2018-2023)
Table 17. Global Biologics Sale Price by Application (2018-2023) & (USD/MT)
Table 18. Global Biologics Sales by Company (2018-2023) & (K MT)
Table 19. Global Biologics Sales Market Share by Company (2018-2023)
Table 20. Global Biologics Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Biologics Revenue Market Share by Company (2018-2023)
Table 22. Global Biologics Sale Price by Company (2018-2023) & (USD/MT)
Table 23. Key Manufacturers Biologics Producing Area Distribution and Sales Area
Table 24. Players Biologics Products Offered
Table 25. Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Biologics Sales by Geographic Region (2018-2023) & (K MT)
Table 29. Global Biologics Sales Market Share Geographic Region (2018-2023)
Table 30. Global Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Biologics Sales by Country/Region (2018-2023) & (K MT)
Table 33. Global Biologics Sales Market Share by Country/Region (2018-2023)
Table 34. Global Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Biologics Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Biologics Sales by Country (2018-2023) & (K MT)
Table 37. Americas Biologics Sales Market Share by Country (2018-2023)
Table 38. Americas Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Biologics Revenue Market Share by Country (2018-2023)
Table 40. Americas Biologics Sales by Type (2018-2023) & (K MT)
Table 41. Americas Biologics Sales by Application (2018-2023) & (K MT)
Table 42. APAC Biologics Sales by Region (2018-2023) & (K MT)
Table 43. APAC Biologics Sales Market Share by Region (2018-2023)
Table 44. APAC Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Biologics Revenue Market Share by Region (2018-2023)
Table 46. APAC Biologics Sales by Type (2018-2023) & (K MT)
Table 47. APAC Biologics Sales by Application (2018-2023) & (K MT)
Table 48. Europe Biologics Sales by Country (2018-2023) & (K MT)
Table 49. Europe Biologics Sales Market Share by Country (2018-2023)
Table 50. Europe Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Biologics Revenue Market Share by Country (2018-2023)
Table 52. Europe Biologics Sales by Type (2018-2023) & (K MT)
Table 53. Europe Biologics Sales by Application (2018-2023) & (K MT)
Table 54. Middle East & Africa Biologics Sales by Country (2018-2023) & (K MT)
Table 55. Middle East & Africa Biologics Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Biologics Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Biologics Sales by Type (2018-2023) & (K MT)
Table 59. Middle East & Africa Biologics Sales by Application (2018-2023) & (K MT)
Table 60. Key Market Drivers & Growth Opportunities of Biologics
Table 61. Key Market Challenges & Risks of Biologics
Table 62. Key Industry Trends of Biologics
Table 63. Biologics Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Biologics Distributors List
Table 66. Biologics Customer List
Table 67. Global Biologics Sales Forecast by Region (2024-2029) & (K MT)
Table 68. Global Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Biologics Sales Forecast by Country (2024-2029) & (K MT)
Table 70. Americas Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Biologics Sales Forecast by Region (2024-2029) & (K MT)
Table 72. APAC Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Biologics Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Europe Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Biologics Sales Forecast by Country (2024-2029) & (K MT)
Table 76. Middle East & Africa Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Biologics Sales Forecast by Type (2024-2029) & (K MT)
Table 78. Global Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Biologics Sales Forecast by Application (2024-2029) & (K MT)
Table 80. Global Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Eli Lilly & Company Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 82. Eli Lilly & Company Biologics Product Portfolios and Specifications
Table 83. Eli Lilly & Company Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 84. Eli Lilly & Company Main Business
Table 85. Eli Lilly & Company Latest Developments
Table 86. Samsung Biologics Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 87. Samsung Biologics Biologics Product Portfolios and Specifications
Table 88. Samsung Biologics Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 89. Samsung Biologics Main Business
Table 90. Samsung Biologics Latest Developments
Table 91. F Hoffman La Roche Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 92. F Hoffman La Roche Biologics Product Portfolios and Specifications
Table 93. F Hoffman La Roche Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 94. F Hoffman La Roche Main Business
Table 95. F Hoffman La Roche Latest Developments
Table 96. Celltrion Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 97. Celltrion Biologics Product Portfolios and Specifications
Table 98. Celltrion Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 99. Celltrion Main Business
Table 100. Celltrion Latest Developments
Table 101. Addgene Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 102. Addgene Biologics Product Portfolios and Specifications
Table 103. Addgene Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 104. Addgene Main Business
Table 105. Addgene Latest Developments
Table 106. Amgen Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 107. Amgen Biologics Product Portfolios and Specifications
Table 108. Amgen Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 109. Amgen Main Business
Table 110. Amgen Latest Developments
Table 111. Abbvie Inc. Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 112. Abbvie Inc. Biologics Product Portfolios and Specifications
Table 113. Abbvie Inc. Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 114. Abbvie Inc. Main Business
Table 115. Abbvie Inc. Latest Developments
Table 116. Sanofi Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 117. Sanofi Biologics Product Portfolios and Specifications
Table 118. Sanofi Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 119. Sanofi Main Business
Table 120. Sanofi Latest Developments
Table 121. Pfizer Inc. Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 122. Pfizer Inc. Biologics Product Portfolios and Specifications
Table 123. Pfizer Inc. Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 124. Pfizer Inc. Main Business
Table 125. Pfizer Inc. Latest Developments
Table 126. Merck & Co. Inc. Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 127. Merck & Co. Inc. Biologics Product Portfolios and Specifications
Table 128. Merck & Co. Inc. Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 129. Merck & Co. Inc. Main Business
Table 130. Merck & Co. Inc. Latest Developments
Table 131. Novo Nordisk A/S Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 132. Novo Nordisk A/S Biologics Product Portfolios and Specifications
Table 133. Novo Nordisk A/S Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 134. Novo Nordisk A/S Main Business
Table 135. Novo Nordisk A/S Latest Developments
Table 136. Johnson & Johnson Services Inc. Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 137. Johnson & Johnson Services Inc. Biologics Product Portfolios and Specifications
Table 138. Johnson & Johnson Services Inc. Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 139. Johnson & Johnson Services Inc. Main Business
Table 140. Johnson & Johnson Services Inc. Latest Developments
Table 1. Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Vaccines
Table 5. Major Players of Recombinant Proteins
Table 6. Major Players of Antisense
Table 7. Major Players of RNAi
Table 8. Global Biologics Sales by Type (2018-2023) & (K MT)
Table 9. Global Biologics Sales Market Share by Type (2018-2023)
Table 10. Global Biologics Revenue by Type (2018-2023) & ($ million)
Table 11. Global Biologics Revenue Market Share by Type (2018-2023)
Table 12. Global Biologics Sale Price by Type (2018-2023) & (USD/MT)
Table 13. Global Biologics Sales by Application (2018-2023) & (K MT)
Table 14. Global Biologics Sales Market Share by Application (2018-2023)
Table 15. Global Biologics Revenue by Application (2018-2023)
Table 16. Global Biologics Revenue Market Share by Application (2018-2023)
Table 17. Global Biologics Sale Price by Application (2018-2023) & (USD/MT)
Table 18. Global Biologics Sales by Company (2018-2023) & (K MT)
Table 19. Global Biologics Sales Market Share by Company (2018-2023)
Table 20. Global Biologics Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Biologics Revenue Market Share by Company (2018-2023)
Table 22. Global Biologics Sale Price by Company (2018-2023) & (USD/MT)
Table 23. Key Manufacturers Biologics Producing Area Distribution and Sales Area
Table 24. Players Biologics Products Offered
Table 25. Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Biologics Sales by Geographic Region (2018-2023) & (K MT)
Table 29. Global Biologics Sales Market Share Geographic Region (2018-2023)
Table 30. Global Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Biologics Sales by Country/Region (2018-2023) & (K MT)
Table 33. Global Biologics Sales Market Share by Country/Region (2018-2023)
Table 34. Global Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Biologics Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Biologics Sales by Country (2018-2023) & (K MT)
Table 37. Americas Biologics Sales Market Share by Country (2018-2023)
Table 38. Americas Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Biologics Revenue Market Share by Country (2018-2023)
Table 40. Americas Biologics Sales by Type (2018-2023) & (K MT)
Table 41. Americas Biologics Sales by Application (2018-2023) & (K MT)
Table 42. APAC Biologics Sales by Region (2018-2023) & (K MT)
Table 43. APAC Biologics Sales Market Share by Region (2018-2023)
Table 44. APAC Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Biologics Revenue Market Share by Region (2018-2023)
Table 46. APAC Biologics Sales by Type (2018-2023) & (K MT)
Table 47. APAC Biologics Sales by Application (2018-2023) & (K MT)
Table 48. Europe Biologics Sales by Country (2018-2023) & (K MT)
Table 49. Europe Biologics Sales Market Share by Country (2018-2023)
Table 50. Europe Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Biologics Revenue Market Share by Country (2018-2023)
Table 52. Europe Biologics Sales by Type (2018-2023) & (K MT)
Table 53. Europe Biologics Sales by Application (2018-2023) & (K MT)
Table 54. Middle East & Africa Biologics Sales by Country (2018-2023) & (K MT)
Table 55. Middle East & Africa Biologics Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Biologics Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Biologics Sales by Type (2018-2023) & (K MT)
Table 59. Middle East & Africa Biologics Sales by Application (2018-2023) & (K MT)
Table 60. Key Market Drivers & Growth Opportunities of Biologics
Table 61. Key Market Challenges & Risks of Biologics
Table 62. Key Industry Trends of Biologics
Table 63. Biologics Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Biologics Distributors List
Table 66. Biologics Customer List
Table 67. Global Biologics Sales Forecast by Region (2024-2029) & (K MT)
Table 68. Global Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Biologics Sales Forecast by Country (2024-2029) & (K MT)
Table 70. Americas Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Biologics Sales Forecast by Region (2024-2029) & (K MT)
Table 72. APAC Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Biologics Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Europe Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Biologics Sales Forecast by Country (2024-2029) & (K MT)
Table 76. Middle East & Africa Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Biologics Sales Forecast by Type (2024-2029) & (K MT)
Table 78. Global Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Biologics Sales Forecast by Application (2024-2029) & (K MT)
Table 80. Global Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Eli Lilly & Company Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 82. Eli Lilly & Company Biologics Product Portfolios and Specifications
Table 83. Eli Lilly & Company Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 84. Eli Lilly & Company Main Business
Table 85. Eli Lilly & Company Latest Developments
Table 86. Samsung Biologics Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 87. Samsung Biologics Biologics Product Portfolios and Specifications
Table 88. Samsung Biologics Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 89. Samsung Biologics Main Business
Table 90. Samsung Biologics Latest Developments
Table 91. F Hoffman La Roche Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 92. F Hoffman La Roche Biologics Product Portfolios and Specifications
Table 93. F Hoffman La Roche Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 94. F Hoffman La Roche Main Business
Table 95. F Hoffman La Roche Latest Developments
Table 96. Celltrion Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 97. Celltrion Biologics Product Portfolios and Specifications
Table 98. Celltrion Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 99. Celltrion Main Business
Table 100. Celltrion Latest Developments
Table 101. Addgene Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 102. Addgene Biologics Product Portfolios and Specifications
Table 103. Addgene Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 104. Addgene Main Business
Table 105. Addgene Latest Developments
Table 106. Amgen Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 107. Amgen Biologics Product Portfolios and Specifications
Table 108. Amgen Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 109. Amgen Main Business
Table 110. Amgen Latest Developments
Table 111. Abbvie Inc. Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 112. Abbvie Inc. Biologics Product Portfolios and Specifications
Table 113. Abbvie Inc. Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 114. Abbvie Inc. Main Business
Table 115. Abbvie Inc. Latest Developments
Table 116. Sanofi Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 117. Sanofi Biologics Product Portfolios and Specifications
Table 118. Sanofi Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 119. Sanofi Main Business
Table 120. Sanofi Latest Developments
Table 121. Pfizer Inc. Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 122. Pfizer Inc. Biologics Product Portfolios and Specifications
Table 123. Pfizer Inc. Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 124. Pfizer Inc. Main Business
Table 125. Pfizer Inc. Latest Developments
Table 126. Merck & Co. Inc. Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 127. Merck & Co. Inc. Biologics Product Portfolios and Specifications
Table 128. Merck & Co. Inc. Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 129. Merck & Co. Inc. Main Business
Table 130. Merck & Co. Inc. Latest Developments
Table 131. Novo Nordisk A/S Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 132. Novo Nordisk A/S Biologics Product Portfolios and Specifications
Table 133. Novo Nordisk A/S Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 134. Novo Nordisk A/S Main Business
Table 135. Novo Nordisk A/S Latest Developments
Table 136. Johnson & Johnson Services Inc. Basic Information, Biologics Manufacturing Base, Sales Area and Its Competitors
Table 137. Johnson & Johnson Services Inc. Biologics Product Portfolios and Specifications
Table 138. Johnson & Johnson Services Inc. Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 139. Johnson & Johnson Services Inc. Main Business
Table 140. Johnson & Johnson Services Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biologics
Figure 2. Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologics Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Vaccines
Figure 11. Product Picture of Recombinant Proteins
Figure 12. Product Picture of Antisense
Figure 13. Product Picture of RNAi
Figure 14. Global Biologics Sales Market Share by Type in 2022
Figure 15. Global Biologics Revenue Market Share by Type (2018-2023)
Figure 16. Biologics Consumed in Infectious Diseases
Figure 17. Global Biologics Market: Infectious Diseases (2018-2023) & (K MT)
Figure 18. Biologics Consumed in Oncology
Figure 19. Global Biologics Market: Oncology (2018-2023) & (K MT)
Figure 20. Biologics Consumed in Immunology
Figure 21. Global Biologics Market: Immunology (2018-2023) & (K MT)
Figure 22. Biologics Consumed in Autoimmune Diseases
Figure 23. Global Biologics Market: Autoimmune Diseases (2018-2023) & (K MT)
Figure 24. Global Biologics Sales Market Share by Application (2022)
Figure 25. Global Biologics Revenue Market Share by Application in 2022
Figure 26. Biologics Sales Market by Company in 2022 (K MT)
Figure 27. Global Biologics Sales Market Share by Company in 2022
Figure 28. Biologics Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Biologics Revenue Market Share by Company in 2022
Figure 30. Global Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Biologics Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Biologics Sales 2018-2023 (K MT)
Figure 33. Americas Biologics Revenue 2018-2023 ($ Millions)
Figure 34. APAC Biologics Sales 2018-2023 (K MT)
Figure 35. APAC Biologics Revenue 2018-2023 ($ Millions)
Figure 36. Europe Biologics Sales 2018-2023 (K MT)
Figure 37. Europe Biologics Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Biologics Sales 2018-2023 (K MT)
Figure 39. Middle East & Africa Biologics Revenue 2018-2023 ($ Millions)
Figure 40. Americas Biologics Sales Market Share by Country in 2022
Figure 41. Americas Biologics Revenue Market Share by Country in 2022
Figure 42. Americas Biologics Sales Market Share by Type (2018-2023)
Figure 43. Americas Biologics Sales Market Share by Application (2018-2023)
Figure 44. United States Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Biologics Sales Market Share by Region in 2022
Figure 49. APAC Biologics Revenue Market Share by Regions in 2022
Figure 50. APAC Biologics Sales Market Share by Type (2018-2023)
Figure 51. APAC Biologics Sales Market Share by Application (2018-2023)
Figure 52. China Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Biologics Sales Market Share by Country in 2022
Figure 60. Europe Biologics Revenue Market Share by Country in 2022
Figure 61. Europe Biologics Sales Market Share by Type (2018-2023)
Figure 62. Europe Biologics Sales Market Share by Application (2018-2023)
Figure 63. Germany Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Biologics Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Biologics Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Biologics Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Biologics Sales Market Share by Application (2018-2023)
Figure 72. Egypt Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Biologics in 2022
Figure 78. Manufacturing Process Analysis of Biologics
Figure 79. Industry Chain Structure of Biologics
Figure 80. Channels of Distribution
Figure 81. Global Biologics Sales Market Forecast by Region (2024-2029)
Figure 82. Global Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Biologics Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Biologics
Figure 2. Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologics Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Vaccines
Figure 11. Product Picture of Recombinant Proteins
Figure 12. Product Picture of Antisense
Figure 13. Product Picture of RNAi
Figure 14. Global Biologics Sales Market Share by Type in 2022
Figure 15. Global Biologics Revenue Market Share by Type (2018-2023)
Figure 16. Biologics Consumed in Infectious Diseases
Figure 17. Global Biologics Market: Infectious Diseases (2018-2023) & (K MT)
Figure 18. Biologics Consumed in Oncology
Figure 19. Global Biologics Market: Oncology (2018-2023) & (K MT)
Figure 20. Biologics Consumed in Immunology
Figure 21. Global Biologics Market: Immunology (2018-2023) & (K MT)
Figure 22. Biologics Consumed in Autoimmune Diseases
Figure 23. Global Biologics Market: Autoimmune Diseases (2018-2023) & (K MT)
Figure 24. Global Biologics Sales Market Share by Application (2022)
Figure 25. Global Biologics Revenue Market Share by Application in 2022
Figure 26. Biologics Sales Market by Company in 2022 (K MT)
Figure 27. Global Biologics Sales Market Share by Company in 2022
Figure 28. Biologics Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Biologics Revenue Market Share by Company in 2022
Figure 30. Global Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Biologics Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Biologics Sales 2018-2023 (K MT)
Figure 33. Americas Biologics Revenue 2018-2023 ($ Millions)
Figure 34. APAC Biologics Sales 2018-2023 (K MT)
Figure 35. APAC Biologics Revenue 2018-2023 ($ Millions)
Figure 36. Europe Biologics Sales 2018-2023 (K MT)
Figure 37. Europe Biologics Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Biologics Sales 2018-2023 (K MT)
Figure 39. Middle East & Africa Biologics Revenue 2018-2023 ($ Millions)
Figure 40. Americas Biologics Sales Market Share by Country in 2022
Figure 41. Americas Biologics Revenue Market Share by Country in 2022
Figure 42. Americas Biologics Sales Market Share by Type (2018-2023)
Figure 43. Americas Biologics Sales Market Share by Application (2018-2023)
Figure 44. United States Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Biologics Sales Market Share by Region in 2022
Figure 49. APAC Biologics Revenue Market Share by Regions in 2022
Figure 50. APAC Biologics Sales Market Share by Type (2018-2023)
Figure 51. APAC Biologics Sales Market Share by Application (2018-2023)
Figure 52. China Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Biologics Sales Market Share by Country in 2022
Figure 60. Europe Biologics Revenue Market Share by Country in 2022
Figure 61. Europe Biologics Sales Market Share by Type (2018-2023)
Figure 62. Europe Biologics Sales Market Share by Application (2018-2023)
Figure 63. Germany Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Biologics Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Biologics Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Biologics Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Biologics Sales Market Share by Application (2018-2023)
Figure 72. Egypt Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Biologics in 2022
Figure 78. Manufacturing Process Analysis of Biologics
Figure 79. Industry Chain Structure of Biologics
Figure 80. Channels of Distribution
Figure 81. Global Biologics Sales Market Forecast by Region (2024-2029)
Figure 82. Global Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Biologics Revenue Market Share Forecast by Application (2024-2029)
